Acorah Software Products - Accounts Production 16.5.460 false true 31 January 2024 1 February 2023 false true No description of principal activity 1 February 2024 31 January 2025 31 January 2025 13146970 Dr Yasir Al-Athari Mrs Mina Mahawish iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13146970 2024-01-31 13146970 2025-01-31 13146970 2024-02-01 2025-01-31 13146970 frs-core:CurrentFinancialInstruments 2025-01-31 13146970 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13146970 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 13146970 frs-bus:Micro-entities 2024-02-01 2025-01-31 13146970 frs-bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 13146970 frs-bus:Director1 2024-02-01 2025-01-31 13146970 frs-bus:CompanySecretary1 2024-02-01 2025-01-31 13146970 2023-01-31 13146970 2024-01-31 13146970 2023-02-01 2024-01-31 13146970 frs-core:CurrentFinancialInstruments 2024-01-31
Registered number: 13146970
Yclinic Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2025
Yclinic Ltd
Accountant's Report
For The Year Ended 31 January 2025
Accountant's Report
Report to the director on the preparation of the unaudited statutory accounts of Yclinic Ltd for the year ended 31 January 2025
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Yclinic Ltd for the year ended 31 January 2025 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the accounting records and from information and explanations you have given to us.
As a practising member of the Institute of Financial Accountants (IFA), we are subject to its ethical and other professional requirements which are detailed at https://www.ifa.org.uk/about-us/acting-in-the-public-interest/memberregulations.
This report is made solely to the director of Yclinic Ltd , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Yclinic Ltd and state those matters that we have agreed to state to the director of Yclinic Ltd , as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Yclinic Ltd and its director, as a body, for our work or for this report.
It is your duty to ensure that Yclinic Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Yclinic Ltd . You consider that Yclinic Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of Yclinic Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.

SAM AND CO ACCOUNTANTS
06/10/2025

Sam & Co Accountants
MAAT membeship no :20422130 & ACPA Membership No: 01298415A
479 Chester Road
Old Trafford
Manchester
M16 9HF
Page 1
Yclinic Ltd
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 13146970

| 2025 | 2024
--- | --- | ---
|  | £ | £
Current assets |  | 1,599 | 15,675
Creditors: Amounts Falling Due Within One Year |  | (447 ) | (12,737 )
NET CURRENT ASSETS |  | 1,152 | 2,938
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 1,152 | 2,938
NET ASSETS |  | 1,152 | 2,938
CAPITAL AND RESERVES |  | 1,152 | 2,938

## Notes

1. General Information
Yclinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13146970 . The registered office is 4 Mill Lane, Cheadle Hulme, Cheadle, SK8 5PG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 2)
1 2
3. Directors Advances, Credits and Guarantees
Dividends paid to

| 2025 | 2024
--- | --- | ---
| £ | £
Dr Yasir Al-Athari | 1,000 | 25,500

4. Dividends paid to shareholders
Mrs Mina Mahawish as a company shareholder has received a total of £25,500 dividend
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Yasir Al-Athari Director
06/10/2025